NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmaceutical Research Associates Denmark ApS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
7,026
|
5,958
|
5,227 |
| Total assets |
71,740
|
58,114
|
27,532 |
| Current assets |
71,740
|
58,092
|
0 |
| Current liabilities |
39,571
|
32,301
|
6,246 |
| Equity capital |
32,168
|
25,813
|
21,286 |
| - share capital |
123
|
119
|
120 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.8%
|
44.4%
|
77.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
181.3%
|
179.8%
|
0% |
| Return on equity (ROE) |
21.8%
|
23.1%
|
24.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.